These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 17437731

  • 1. Comparison of efficacy and safety of lower-dose to higher-dose oral prednisone after percutaneous coronary interventions (the IMPRESS-LD study).
    Ferrero V, Ribichini F, Rognoni A, Marino P, Brunelleschi S, Vassanelli C.
    Am J Cardiol; 2007 Apr 15; 99(8):1082-6. PubMed ID: 17437731
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F, Tomai F, De Luca G, Boccuzzi G, Presbitero P, Pesarini G, Ferrero V, Ghini AS, Pastori F, De Luca L, Zavalloni D, Soregaroli D, Garbo R, Franchi E, Marino P, Minelli M, Vassanelli C.
    J Cardiovasc Med (Hagerstown); 2009 Feb 15; 10(2):192-9. PubMed ID: 19377384
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y study.
    Ribichini F, Ferrero V, Rognoni A, Marino P, Brunelleschi S, Vassanelli C.
    J Interv Cardiol; 2007 Apr 15; 20(2):114-21. PubMed ID: 17391219
    [Abstract] [Full Text] [Related]

  • 4. Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial.
    Ribichini F, Tomai F, De Luca G, Boccuzzi G, Presbitero P, Pesarini G, Ferrero V, Ghini AS, Abukaresh R, Aurigemma C, De Luca L, Zavalloni D, Soregaroli D, Marino P, Garbo R, Zanolla L, Vassanelli C, CEREA-DES investigators.
    Am J Med; 2011 May 15; 124(5):434-43. PubMed ID: 21531233
    [Abstract] [Full Text] [Related]

  • 5. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
    Maresta A, Varani E, Balducelli M, Varbella F, Lettieri C, Uguccioni L, Sangiorgio P, Zoccai GB, DESSERT Investigators.
    Am J Cardiol; 2008 Jun 01; 101(11):1560-6. PubMed ID: 18489933
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study.
    Ribichini F, Tomai F, Ferrero V, Versaci F, Boccuzzi G, Proietti I, Prati F, Crea F, Vassanelli C.
    EuroIntervention; 2005 Aug 01; 1(2):173-80. PubMed ID: 19758899
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L, Chen LL, Lin CG, Peng YF, Zheng XC, Luo YK, Zhang FL, Chen JH, Yan XP, Huang ZR.
    Chin Med J (Engl); 2008 Aug 20; 121(16):1518-23. PubMed ID: 18982862
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.
    Minerva Cardioangiol; 2008 Feb 10; 56(1):35-42. PubMed ID: 18432167
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS, Jibrin I, Abraham D, Merriman B, Wenz C, Bahr RD.
    Crit Pathw Cardiol; 2008 Dec 10; 7(4):232-8. PubMed ID: 19050419
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes.
    Pinkau T, Mann JF, Ndrepepa G, Mehilli J, Hadamitzky M, Braun S, Kastrati A, Schömig A.
    Am J Kidney Dis; 2004 Oct 10; 44(4):627-35. PubMed ID: 15384013
    [Abstract] [Full Text] [Related]

  • 19. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW.
    Circulation; 2008 Sep 09; 118(11):1146-54. PubMed ID: 18725490
    [Abstract] [Full Text] [Related]

  • 20. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y, Zheng Z, Xu B, Zhang S, Li W, Gao R, Hu S.
    Circulation; 2009 Apr 21; 119(15):2040-50. PubMed ID: 19349321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.